Dr. James M. Ford MD?
Update this Profile
Dr. James M. Ford MD, Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. James M. Ford MD

Hematologist-Oncologist | Hematology & Oncology

5/5(1)
300 Pasteur Dr Stanford CA, 94305
Rating

5/5

About

Dr. James Ford is a hematologist oncologist practicing in Stanford, CA. Dr. Ford specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2005

Provider Details

MaleEnglish

Expert Publications

Data provided by the National Library of Medicine

Fellowships

  • Stanford University School of Medicine,Stanford, Ca, United States   1994

Publications

  • JOURL OF CLINICAL ONCOLOGYMolecular Profiling of Gastric Cancer: Toward Persolized Cancer Medicine2013
  • SCIENCE TRANSLATIOL MEDICINELupus Antibody Tops Cancer Cells2012
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONLynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack2012
  • JOURL OF CLINICAL ONCOLOGYLong-Term Survivors of Gastric Cancer: A California Population-Based Study2012
  • CANCER JOURLGenetic Testing by Cancer Site Stomach2012
  • D REPAIRBreast cancers with compromised D repair exhibit selective sensitivity to elesclomol2012
  • ANLS OF INTERL MEDICINEStrategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost2011
  • JOURL OF THE TIOL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
  • CANCER RESEARCHDefective Repair of Oxidative D Damage in Triple2009
  • JOURL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
  • ANLS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONPredicting and preventing hereditary colorectal cancer2006
  • CANCER RESEARCHMolecular inversion probe alysis of gene copy alterations reveals distinct categories of colorectal2006
  • EMBO JOURLOpposing effects of the UV lesion repair protein XPA2006
  • JOURL OF BIOLOGICAL CHEMISTRYIn vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product2003
  • D REPAIRp53 and regulation of D damage recognition during nucleotide excision repair2003
  • D REPAIRThe DDB2 nucleotide excision repair gene product p48 enhances global genomic repair2003
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMp53 and D damage-inducible expression of the xeroderma pigmentosum group C gene2002
  • TURE GENETICSBRCA1 induces D damage recognition factors and enhances nucleotide excision repair2002
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMExpression of the p48 xeroderma pigmentosum gene is p53-dependent1999
  • JOURL OF BIOLOGICAL CHEMISTRYExpression of wild-type p53 is required for efficient global genomic nucleotide excision repair in1997
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMLI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL D1995
  • Jourl of the American Medical Informatics AssociationDymic contrast-enhanced MRI2013
  • Jourl of the tiol Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
  • ANLS OF SURGICAL ONCOLOGYSeventh Edition (2010) of the AJCC2013
  • JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKChest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • JOURL OF CLINICAL ONCOLOGYFamily History As a Positive Prognostic Factor in Gastric Cancer2012
  • Genes & cancerIdentification of a Functiol In Vivo p53 Response Element2012
  • ANLS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
  • CANCERIntensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell2011
  • Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., NoComparison of Intensity-Modulated Radiotherapy2010
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION2010
  • CANCER RESEARCHOncogenic BRAF Mutation with CDKN2A Ictivation Is Characteristic of a Subset of Pediatric Malignt2010
  • JOURL OF TRANSLATIOL MEDICINEIdentification of a biomarker panel using a multiplex proximity ligation2009
  • D REPAIRThe role of the retinoblastoma2009
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGemcitabine chemotherapy2008
  • AMERICAN JOURL OF SURGICAL PATHOLOGYMicrosatellite instability2008
  • AMERICAN JOURL OF SURGICAL PATHOLOGYRisk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)2008
  • BREAST JOURLMagnetic resonce galactography2008
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMHDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombition2007
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONFounder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer2007
  • BREAST JOURLDuctal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage2007
  • MOLECULAR CELLA kise-independent function of c2006
  • Jourl of the tiol Comprehensive Cancer NetworkColorectal Cancer Screening Clinical Practice Guidelines.2006
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a2005
  • MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESISRegulation of D damage recognition and nucleotide excision repair: Another role for p532005
  • JOURL OF CLINICAL ONCOLOGYPhase II study of gefitinib, fluorouracil2005
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer2004
  • CANCERBreast magnetic resonce image screening2004
  • MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCHFunctiol characterization of global genomic D repair and its implications for cancer2003
  • JOURL OF MOLECULAR MEDICINE-JMMBRCA1 and p53: compensatory roles in D repair2003
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMDefective double-strand D break repair and chromosomal translocations by MYC overexpression2003
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil2003
  • Jourl of biomedicine & biotechnologyD Damage, Repair, and Diseases.2002
  • JOURL OF BIOLOGICAL CHEMISTRYThe p53-regulated cyclin-dependent kise inhibitor2001
  • AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSProtracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 52001
  • Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., ObePreoperative chemoradiation for margilly resectable adenocarcinoma of the pancreas2001
  • ARCHIVES OF SURGERYAdjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Prelimiry report2001
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAdjuvant radiotherapy2000
  • MUTATION RESEARCH-D REPAIRDecreased UV sensitivity2000
  • MOLECULAR AND CELLULAR BIOLOGYp53-mediated D repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and2000
  • ANLS OF SURGICAL ONCOLOGYChemoradiotherapy in the magement of localized tumors of the pancreas1999
  • JOURL OF BIOLOGICAL CHEMISTRYHepatitis B x protein inhibits p53-dependent D repair in primary mouse hepatocytes1998
  • GENETIC INSTABILITY AND TUMORIGENESISRole of D excision repair gene defects in the etiology of cancer1997
  • EUROPEAN JOURL OF CANCERExperimental reversal of P-glycoprotein1996
  • MOLECULAR CARCINOGENESISPREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED D1994
  • CANCER LETTERSMODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENTIOMERS1991
  • MOLECULAR PHARMACOLOGYBIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENTIOMERS1990
  • JOURL OF CLINICAL ONCOLOGYTOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE1989
  • JOURNAL OF CLINICAL ONCOLOGYMolecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine2013
  • SCIENCE TRANSLATIONAL MEDICINELupus Antibody Tops Cancer Cells2012
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONLynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack2012
  • JOURNAL OF CLINICAL ONCOLOGYLong-Term Survivors of Gastric Cancer: A California Population-Based Study2012
  • CANCER JOURNALGenetic Testing by Cancer Site Stomach2012
  • DNA REPAIRBreast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol2012
  • Breast cancer research : BCRIs breast cancer a part of Lynch syndrome?2012
  • ANNALS OF INTERNAL MEDICINEStrategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost2011
  • BMC pharmacologyEnhanced sensitivity to cisplatin2011
  • CANCER RESEARCHSynergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly2010
  • JOURNAL OF THE NATIONAL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
  • CANCER RESEARCHDefective Repair of Oxidative DNA Damage in Triple2009
  • JOURNAL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
  • CANCERHereditary diffuse gastric cancer - Implications of genetic testing for screening2008
  • ANNALS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONPredicting and preventing hereditary colorectal cancer2006
  • CANCER RESEARCHMolecular inversion probe analysis of gene copy alterations reveals distinct categories of2006
  • EMBO JOURNALOpposing effects of the UV lesion repair protein XPA2006
  • JOURNAL OF BIOLOGICAL CHEMISTRYIn vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product2003
  • DNA REPAIRp53 and regulation of DNA damage recognition during nucleotide excision repair2003
  • DNA REPAIRThe DDB2 nucleotide excision repair gene product p48 enhances global genomic repair2003
  • CARCINOGENESISp53 responsive nucleotide excision repair gene products p48 and XPC, but not p532003
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES Op53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene2002
  • NATURE GENETICSBRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair2002
  • MOLECULAR CELLXeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis2000
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OExpression of the p48 xeroderma pigmentosum gene is p53-dependent1999
  • JOURNAL OF BIOLOGICAL CHEMISTRYExpression of wild-type p53 is required for efficient global genomic nucleotide excision repair in1997
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OLI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL DNA1995
  • Breast cancer research and treatmentA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.2013
  • Journal of the American Medical Informatics AssociationDynamic contrast-enhanced MRI2013
  • Journal of the National Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
  • ANNALS OF SURGICAL ONCOLOGYSeventh Edition (2010) of the AJCC2013
  • FAMILIAL CANCERBreast cancer risk factors differ between Asian and white women with BRCA1/2 mutations2012
  • JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKChest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early2012
  • MODERN PATHOLOGYClinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma2012
  • JOURNAL OF CLINICAL ONCOLOGYFamily History As a Positive Prognostic Factor in Gastric Cancer2012
  • Genes & cancerIdentification of a Functional In Vivo p53 Response Element2012
  • BioDiscoveryIdentification of a novel deletion mutant strain in Saccharomyces cerevisiae that results in a0
  • APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGYHER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population2012
  • ANNALS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
  • CANCERIntensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell2011
  • MODERN PATHOLOGYA two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal2011
  • BREAST CANCER RESEARCH AND TREATMENTAsian ethnicity and breast cancer subtypes: a study from the California Cancer Registry2011
  • Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A.Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate2010
  • CLINICAL CANCER RESEARCHPoly(ADP-Ribose) Polymerase Inhibition: Targeted Therapy for Triple-Negative Breast Cancer2010
  • Clinical advances in hematology & oncology : H&OPARP inhibitors in breast cancer.2010
  • Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., NoComparison of Intensity-Modulated Radiotherapy2010
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION2010
  • HUMAN PATHOLOGYHereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation2010
  • COLORECTAL DISEASEPathological response after chemoradiation for T3 rectal cancer2010
  • Colorectal diseasePathological response after chemoradiation for T3 rectal cancer.2010
  • CLINICAL BREAST CANCERNovel Treatment Approaches for Triple-Negative Breast Cancer2010
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONLonger Relative Telomere Length in Blood from Women with Sporadic2010
  • CANCER RESEARCHOncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric2010
  • Current breast cancer reportsPARP Inhibitors for the Treatment and Prevention of Breast Cancer.2010
  • DISEASES OF THE ESOPHAGUSMultimodality treatment with intensity modulated radiation therapy for esophageal cancer2010
  • JOURNAL OF TRANSLATIONAL MEDICINEIdentification of a biomarker panel using a multiplex proximity ligation2009
  • BREAST CANCER RESEARCH AND TREATMENTA BRCA2 founder mutation2009
  • DNA REPAIRThe role of the retinoblastoma2009
  • CLINICAL NUCLEAR MEDICINEDetection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT2009
  • CANCERStereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas2009
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGemcitabine chemotherapy2008
  • AMERICAN JOURNAL OF SURGICAL PATHOLOGYMicrosatellite instability2008
  • FAMILIAL CANCERCancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers2008
  • AMERICAN JOURNAL OF SURGICAL PATHOLOGYRisk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)2008
  • FAMILIAL CANCERCharacterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family2008
  • PEDIATRIC BLOOD & CANCERIdentification of a novel p53 in-frame deletion in a Li-Fraumeni-like family2008
  • BREAST JOURNALMagnetic resonance galactography2008
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OHDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination2007
  • CANCER GENETICS AND CYTOGENETICSA carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature2007
  • GENETICS IN MEDICINEIdentification of an intronic single nucleotide polymorphism leading to allele dropout during2007
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONFounder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer2007
  • BREAST JOURNALDuctal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage2007
  • MOLECULAR PHARMACOLOGYReversal of stathmin-mediated resistance to paclitaxel2007
  • CLINICAL CANCER RESEARCHGerm line mutations of mismatch repair genes2006
  • MOLECULAR CELLA kinase-independent function of c2006
  • Journal of the National Comprehensive Cancer NetworkColorectal Cancer Screening Clinical Practice Guidelines.2006
  • Daly, M. B., Axilbund, J. E., Bryant, E., Buys, S., Eng, C., Friedman,Genetic/familial high-risk assessment: breast and ovarian.0
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a2005
  • MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESISRegulation of DNA damage recognition and nucleotide excision repair: Another role for p532005
  • HEALTH EXPECTATIONSOpinions of women with high inherited breast cancer risk about prophylactic mastectomy2005
  • JOURNAL OF CLINICAL ONCOLOGYPhase II study of gefitinib, fluorouracil2005
  • CLINICAL CANCER RESEARCHCharacterization of a recurrent germ line mutation of the E-cadherin gene2005
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONDuctal lavage of fluid-yielding and non2005
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer2004
  • CANCERBreast magnetic resonance image screening2004
  • MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCHFunctional characterization of global genomic DNA repair and its implications for cancer2003
  • JOURNAL OF MOLECULAR MEDICINE-JMMBRCA1 and p53: compensatory roles in DNA repair2003
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES ODefective double-strand DNA break repair and chromosomal translocations by MYC overexpression2003
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPhase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil2003
  • Journal of biomedicine & biotechnologyDNA Damage, Repair, and Diseases.2002
  • JOURNAL OF BIOLOGICAL CHEMISTRYThe p53-regulated cyclin-dependent kinase inhibitor2001
  • AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALSProtracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 52001
  • Mehta, V. K., Poen, J., Ford, J., Edelstein, P. S., Vierra, M., BastidRadiotherapy, concomitant protracted-venous-infusion 5-fluorouracil2001
  • Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., ObePreoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas2001
  • ARCHIVES OF SURGERYAdjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Preliminary report2001
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAdjuvant radiotherapy2000
  • MOLECULAR AND CELLULAR BIOLOGYProapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p532000
  • MOLECULAR CARCINOGENESISReduced global genomic repair of ultraviolet light2000
  • MUTATION RESEARCH-DNA REPAIRDecreased UV sensitivity2000
  • MOLECULAR AND CELLULAR BIOLOGYp53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and2000
  • ANNALS OF SURGICAL ONCOLOGYChemoradiotherapy in the management of localized tumors of the pancreas1999
  • JOURNAL OF BIOLOGICAL CHEMISTRYHepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes1998
  • CANCER RESEARCHHuman fibroblasts expressing the human papillomavirus E6 gene are deficient1998
  • GENETIC INSTABILITY AND TUMORIGENESISRole of DNA excision repair gene defects in the etiology of cancer1997
  • EUROPEAN JOURNAL OF CANCERExperimental reversal of P-glycoprotein1996
  • Cancer treatment and researchP-glycoprotein-mediated multidrug resistance1996
  • HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICAMODULATORS OF MULTIDRUG-RESISTANCE - PRECLINICAL STUDIES1995
  • MOLECULAR CARCINOGENESISPREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED DNA1994
  • CYTOTECHNOLOGYPHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE1993
  • CANCER RESEARCHEFFECT OF BUTHIONINE SULFOXIMINE ON TOXICITY OF VERAPAMIL AND DOXORUBICIN TO MULTIDRUG RESISTANT1991
  • CANCER LETTERSMODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENANTIOMERS1991
  • PHARMACOLOGICAL REVIEWSPHARMACOLOGY OF DRUGS THAT ALTER MULTIDRUG RESISTANCE IN CANCER1990
  • MOLECULAR PHARMACOLOGYBIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENANTIOMERS1990
  • CANCER RESEARCHCELLULAR AND BIOCHEMICAL1990
  • JOURNAL OF CLINICAL ONCOLOGYTOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE1989
  • MOLECULAR PHARMACOLOGYSTRUCTURAL FEATURES DETERMINING ACTIVITY OF PHENOTHIAZINES AND RELATED DRUGS FOR INHIBITION OF CELL1989

Dr. James M. Ford MD's Practice location

Practice At 300 Pasteur Dr

300 Pasteur Dr -
Stanford, CA 94305
Get Direction
New patients: 650-498-5710, 650-723-4000, 650-723-6762

Dr. James M. Ford MD's reviews

(1)
Write Review

Patient Experience with Dr. Ford


5.0

Based on 1 reviews

Dr. James M. Ford MD has a rating of 5 out of 5 stars based on the reviews from 1 patient. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

  • Survey Shows Lack of Blood Cancer Knowledge Among Americans

    If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...

  • How Dogs Are Helping with Lymphoma Research

    According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...

  • Mr. T's Lessons on Life and Lymphoma

    There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...

  • Superheroes Unite For Elementary Student Fighting Lymphoma

    Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

  • Make-A-Wish Makes a Movie Star

    Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...

  • The Effect of Sunshine on Lymphoma

    Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head east 891 ft
Turn right onto Pasteur Drive 698 ft
You have arrived at your destination, on the right

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2864 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2045 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left